Clinical and Dermoscopic evaluation of effectiveness of Metformin vs Pioglitazone in Acanthosis Nigricans.
Phase 4
- Conditions
- Health Condition 1: L83- Acanthosis nigricans
- Registration Number
- CTRI/2023/01/048858
- Lead Sponsor
- KLE Academy of Higher Education and Research - KLE University Grant
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•Adult patients (>=18 years) with acanthosis nigricans attending the outpatient department of dermatology in KLE Prabhakar Kore Hospital
•Patients from whom written informed consent is obtained
Exclusion Criteria
•Patients already taking any oral hypoglycemic drug.
•Patient diagnosed as Type 1 Diabetes Mellitus
•Patient diagnosed as Drug induced AN
•Patients diagnosed as AN due to known malignancy
•Pregnant and lactating mothers
•Known allergic reaction to either Metformin or Pioglitazone
•Contraindicated for taking metformin or Pioglitazone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method